Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  HIV Infection

  Free Subscription


22.11.2021

4 AIDS
4 AIDS Res Hum Retroviruses
2 Ann Intern Med
1 Antimicrob Agents Chemother
2 BMC Neurol
2 BMJ
2 Cancer
2 Clin Infect Dis
1 HIV Med
1 Immunology
3 J Clin Invest
3 J Infect Dis
2 J Virol
2 Lancet Infect Dis
1 Pediatr Infect Dis J
14 PLoS One
5 PLoS Pathog
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS

  1. TOULOUMI G, Thomadakis C, Pantazis N, Papastamopoulos V, et al
    HIV continuum of care: bridging cross-sectional and longitudinal analyses.
    AIDS. 2021 Nov 11. pii: 00002030-900000000-96268.
    PubMed         Abstract available

  2. RAMOS-RINCON JM, Menchi-Elanzi M, Pinargote-Celorio H, Mayoral A, et al
    Trends in hospitalizations and deaths in HIV-Infected patients in Spain over two decades.
    AIDS. 2021 Oct 20. pii: 00002030-900000000-96291.
    PubMed         Abstract available

  3. LUCAS GM, Winslow DL
    New onset kidney impairment in a large pre-exposure prophylaxis demonstration project in New South Wales, Australia.
    AIDS. 2021;35:2395-2397.
    PubMed        

  4. VANHAMEL J, Laga M
    Measuring progress in the roll-out of pre-exposure prophylaxis: from counting what we know, to knowing what to count.
    AIDS. 2021;35:2389-2390.
    PubMed        


    AIDS Res Hum Retroviruses

  5. SABERI P, Campbell C, Lee EY, Guzman J, et al
    Illustrating HIV Cure Research Strategies for the Next Generation of Research Participants: A Research-Community Collaboration.
    AIDS Res Hum Retroviruses. 2021 Nov 15. doi: 10.1089/AID.2021.0149.
    PubMed         Abstract available

  6. SCHIEFFER RJ, Bryndza Tfaily E, D'Aquila RT, Greene G, et al
    Conjoint Analysis of User Acceptability of Sustained Long-Acting Pre-exposure Prophylaxis (PrEP) for HIV.
    AIDS Res Hum Retroviruses. 2021 Nov 13. doi: 10.1089/AID.2021.0075.
    PubMed         Abstract available

  7. JENNINGS L, Kellermann T, Spinelli MA, Nkantsu Z, et al
    Drug resistance, rather than low tenofovir levels in blood or urine, is associated with tenofovir, emtricitabine and efavirenz (TEE) failure in resource-limited settings.
    AIDS Res Hum Retroviruses. 2021 Nov 13. doi: 10.1089/AID.2021.0135.
    PubMed         Abstract available

  8. SUN-SUSLOW N, Balon E, Montoya JL, Saloner R, et al
    Frailty Syndrome is Associated with Poorer Self-Reported Sleep Quality Among Older Persons with Human Immunodeficiency Virus.
    AIDS Res Hum Retroviruses. 2021 Nov 13. doi: 10.1089/AID.2020.0158.
    PubMed         Abstract available


    Ann Intern Med

  9. TURK G, Seiger K, Lian X, Sun W, et al
    A Possible Sterilizing Cure of HIV-1 Infection Without Stem Cell Transplantation.
    Ann Intern Med. 2021 Nov 16. doi: 10.7326/L21-0297.
    PubMed         Abstract available

  10. BLANKSON JN
    The Esperanza Patient: More Hope for a Sterilizing HIV-1 Cure.
    Ann Intern Med. 2021 Nov 16. doi: 10.7326/M21-4336.
    PubMed        


    Antimicrob Agents Chemother

  11. DICKER I, Jeffrey JL, Protack T, Lin Z, et al
    GSK3640254 Is a Novel HIV-1 Maturation Inhibitor With an Optimized Virology Profile.
    Antimicrob Agents Chemother. 2021 Nov 15:AAC0187621. doi: 10.1128/AAC.01876.
    PubMed         Abstract available


    BMC Neurol

  12. STROFFOLINI G, Guastamacchia G, Audagnotto S, Atzori C, et al
    Low cerebrospinal fluid Amyloid-betaeta 1-42 in patients with tuberculous meningitis.
    BMC Neurol. 2021;21:449.
    PubMed         Abstract available

  13. GE W, Zhang Y, Peng C, Li D, et al
    Development and external validation of a nomogram for neurosyphilis diagnosis among non-HIV patients: a cross-sectional study.
    BMC Neurol. 2021;21:451.
    PubMed         Abstract available


    BMJ

  14. SAUL H, Gursul D
    Self-testing for HIV could increase diagnoses in the trans community.
    BMJ. 2021;375:n2633.
    PubMed         Abstract available

  15. WILTON J, Abdia Y, Chong M, Karim ME, et al
    Prescription opioid treatment for non-cancer pain and initiation of injection drug use: large retrospective cohort study.
    BMJ. 2021;375:e066965.
    PubMed         Abstract available


    Cancer

  16. DESAI S, Zhu MJ, Lapidos-Salaiz I
    Cervical cancer prevention: Human papillomavirus testing as primary screening.
    Cancer. 2021 Nov 12. doi: 10.1002/cncr.34006.
    PubMed         Abstract available

  17. SHALTIEL T, Zheng S, Siderides C, Gleeson EM, et al
    Hepatitis C-positive Black patients develop hepatocellular carcinoma at earlier stages of liver disease and present with a more aggressive phenotype.
    Cancer. 2021 Feb 25. doi: 10.1002/cncr.33377.
    PubMed         Abstract available


    Clin Infect Dis

  18. HARRIS TG, Jaszi E, Lamb MR, Laudari CA, et al
    Effects of the COVID-19 Pandemic on HIV Services: Findings from 11 Sub-Saharan African Countries.
    Clin Infect Dis. 2021 Nov 15. pii: 6428385. doi: 10.1093.
    PubMed         Abstract available

  19. MENZA TW, Berry SA, Dombrowski J, Cachay E, et al
    Syphilis testing and diagnosis among people with HIV engaged in care at four United States clinical sites, 2014-2018.
    Clin Infect Dis. 2021 Nov 12. pii: 6426153. doi: 10.1093.
    PubMed         Abstract available


    HIV Med

  20. TARIQ S, Okhai H, Severn A, Sabin CA, et al
    Follicle-stimulating hormone in postmenopausal women living with HIV: a prevalence study.
    HIV Med. 2021 Nov 17. doi: 10.1111/hiv.13205.
    PubMed         Abstract available


    Immunology

  21. MANN JFS, McKay PF, Klein K, Pankrac J, et al
    Blocking T cell egress with FTY720 extends DNA vaccine expression but reduces immunogenicity.
    Immunology. 2021 Nov 14. doi: 10.1111/imm.13429.
    PubMed         Abstract available


    J Clin Invest

  22. QUINN TC
    Forty years of AIDS: a retrospective and the way forward.
    J Clin Invest. 2021;131.
    PubMed        

  23. SCULLY EP, Bryson BD
    Unlocking the complexity of HIV and Mycobacterium tuberculosis coinfection.
    J Clin Invest. 2021;131.
    PubMed         Abstract available

  24. MITCHELL JL, Pollara J, Dietze K, Edwards RW, et al
    Anti-HIV antibody development up to one year after antiretroviral therapy initiation in acute HIV infection.
    J Clin Invest. 2021 Nov 11. pii: 150937. doi: 10.1172/JCI150937.
    PubMed         Abstract available


    J Infect Dis

  25. FULDA ES, Fitch KV, Overton ET, Zanni MV, et al
    COVID-19 Vaccination Rates in a Global HIV Cohort.
    J Infect Dis. 2021 Nov 18. pii: 6431673. doi: 10.1093.
    PubMed         Abstract available

  26. BALAKRISHNA S, Wolfensberger A, Kachalov V, Roth JA, et al
    Decreasing incidence and determinants of Bacterial Pneumonia in people with HIV: The Swiss HIV Cohort Study.
    J Infect Dis. 2021 Nov 18. pii: 6430793. doi: 10.1093.
    PubMed         Abstract available

  27. DUARTE G, Muresan P, Ward S, Laimon L, et al
    Immunogenicity of conjugated and polysaccharide pneumococcal vaccines administered during pregnancy or postpartum to women with HIV.
    J Infect Dis. 2021 Nov 16. pii: 6429421. doi: 10.1093.
    PubMed         Abstract available


    J Virol

  28. ALVARADO-HERNANDEZ B, Ma Y, Sharma NR, Majerciak V, et al
    Protein-RNA interactome analysis reveals wide association of KSHV ORF57 with host non-coding RNAs and polysomes.
    J Virol. 2021 Nov 17:JVI0178221. doi: 10.1128/JVI.01782.
    PubMed         Abstract available

  29. HEMSATH JR, Liaci AM, Rubin JD, Parrett BJ, et al
    Ex Vivo and In Vivo CD46 Receptor Utilization by Species D Human Adenovirus Serotype 26 (HAdV26).
    J Virol. 2021 Nov 17:JVI0082621. doi: 10.1128/JVI.00826.
    PubMed         Abstract available


    Lancet Infect Dis

  30. GOLDSTONE SE, Giuliano AR, Palefsky JM, Lazcano-Ponce E, et al
    Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial.
    Lancet Infect Dis. 2021 Nov 12. pii: S1473-3099(21)00327.
    PubMed         Abstract available

  31. ISMAIL NA, Omar SV, Moultrie H, Bhyat Z, et al
    Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal study.
    Lancet Infect Dis. 2021 Nov 12. pii: S1473-3099(21)00470.
    PubMed         Abstract available


    Pediatr Infect Dis J

  32. LOERINC L, Scheel A, Jordan-Thompson S, Gillespie S, et al
    Incidence, Reinfection, and Discrepancy Between Sexual Practice and Anatomic Site Positivity of Sexually Transmitted Infections in Youth With HIV.
    Pediatr Infect Dis J. 2021 Nov 9. pii: 00006454-900000000-95630.
    PubMed         Abstract available


    PLoS One

  33. CASTRO-GRANELL V, Garin N, Jaen A, Cenoz S, et al
    Prevalence, beliefs and impact of drug-drug interactions between antiretroviral therapy and illicit drugs among people living with HIV in Spain.
    PLoS One. 2021;16:e0260334.
    PubMed         Abstract available

  34. RIVERA-ORTIZ J, Pla-Tenorio J, Cruz ML, Colon K, et al
    Blockade of beta adrenergic receptors protects the blood brain barrier and reduces systemic pathology caused by HIV-1 Nef protein.
    PLoS One. 2021;16:e0259446.
    PubMed         Abstract available

  35. FERRETO LED, Guedes SJKO, Pauli FB, Rovani SS, et al
    Correction: Seroprevalence and associated factors of HIV and Hepatitis C in Brazilian high-security prisons: A state-wide epidemiological study.
    PLoS One. 2021;16:e0260179.
    PubMed         Abstract available

  36. HANLEY S, Moodley D, Naidoo M
    Obesity in young South African women living with HIV: A cross-sectional analysis of risk factors for cardiovascular disease.
    PLoS One. 2021;16:e0255652.
    PubMed         Abstract available

  37. FAUK NK, Ward PR, Hawke K, Mwanri L, et al
    Cultural and religious determinants of HIV transmission: A qualitative study with people living with HIV in Belu and Yogyakarta, Indonesia.
    PLoS One. 2021;16:e0257906.
    PubMed         Abstract available

  38. SEKHON M, van der Straten A
    Pregnant and breastfeeding women's prospective acceptability of two biomedical HIV prevention approaches in Sub Saharan Africa: A multisite qualitative analysis using the Theoretical Framework of Acceptability.
    PLoS One. 2021;16:e0259779.
    PubMed         Abstract available

  39. PAPADOPOULOS AO, Ealand C, Gordhan BG, VanNieuwenhze M, et al
    Characterisation of a putative M23-domain containing protein in Mycobacterium tuberculosis.
    PLoS One. 2021;16:e0259181.
    PubMed         Abstract available

  40. GASKINS M, Sammons MK, Kutscha F, Nast A, et al
    Factors that motivate men who have sex with men in Berlin, Germany, to use or consider using HIV pre-exposure prophylaxis-A multi-methods analysis of data from a multicentre survey.
    PLoS One. 2021;16:e0260168.
    PubMed         Abstract available

  41. JIANU C, Itu-Muresan C, Drugan C, Filipescu I, et al
    Evaluation of several serum interleukins as markers for treatment effectiveness in naive HIV infected patients: A pilot study.
    PLoS One. 2021;16:e0260007.
    PubMed         Abstract available

  42. RWIBASIRA GN, Malamba SS, Musengimana G, Nkunda RCM, et al
    Recent infections among individuals with a new HIV diagnosis in Rwanda, 2018-2020.
    PLoS One. 2021;16:e0259708.
    PubMed         Abstract available

  43. HAYES P, Fernandez N, Ochsenbauer C, Dalel J, et al
    Breadth of CD8 T-cell mediated inhibition of replication of diverse HIV-1 transmitted-founder isolates correlates with the breadth of recognition within a comprehensive HIV-1 Gag, Nef, Env and Pol potential T-cell epitope (PTE) peptide set.
    PLoS One. 2021;16:e0260118.
    PubMed         Abstract available

  44. CHEMTOB D, Weil C, Hannink Attal J, Hawila E, et al
    HIV Pre-Exposure Prophylaxis (PrEP) purchase patterns and STI occurrence among Israeli men: A cohort analysis.
    PLoS One. 2021;16:e0259168.
    PubMed         Abstract available

  45. DES JARLAIS DC, Arasteh K, Huong DT, Oanh KTH, et al
    Using large-scale respondent driven sampling to monitor the end of an HIV epidemic among persons who inject drugs in Hai Phong, Viet Nam.
    PLoS One. 2021;16:e0259983.
    PubMed         Abstract available

  46. VANQA N, Hoddinott G, Mbenyana B, Osman M, et al
    Linkage to TB care: A qualitative study to understand linkage from the patients' perspective in the Western Cape Province, South Africa.
    PLoS One. 2021;16:e0260200.
    PubMed         Abstract available


    PLoS Pathog

  47. ADENIJI OS, Kuri-Cervantes L, Yu C, Xu Z, et al
    Siglec-9 defines and restrains a natural killer subpopulation highly cytotoxic to HIV-infected cells.
    PLoS Pathog. 2021;17:e1010034.
    PubMed         Abstract available

  48. ZHAO Z, Fagerlund R, Tossavainen H, Hopfensperger K, et al
    Evolutionary plasticity of SH3 domain binding by Nef proteins of the HIV-1/SIVcpz lentiviral lineage.
    PLoS Pathog. 2021;17:e1009728.
    PubMed         Abstract available

  49. MIELKE D, Bandawe G, Zheng J, Jones J, et al
    ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection.
    PLoS Pathog. 2021;17:e1010046.
    PubMed         Abstract available

  50. ADRIANO VIEIRA V, Adland E, Malone DFG, Martin MP, et al
    An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+ T-cell-mediated immune control in adults.
    PLoS Pathog. 2021;17:e1010090.
    PubMed         Abstract available

  51. TAYLOR RA, McRaven MD, Carias AM, Anderson MR, et al
    Localization of infection in neonatal rhesus macaques after oral viral challenge.
    PLoS Pathog. 2021;17:e1009855.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  52. SHEVCHENKO AK, Zhernakova DV, Malov SV, Komissarov A, et al
    Genome-wide association study reveals genetic variants associated with HIV-1C infection in a Botswana study population.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: